Researchers’ device tracks biomarkers in sweat, may indicate flare-ups — ScienceDaily

University of Texas at Dallas researchers have designed a wearable device that monitors sweat for biomarkers that could signal flare-ups of inflammatory bowel disease (IBD).

A team of bioengineers demonstrated the wristwatch-like device in a proof-of-concept study funded by the Crohn’s & Colitis Foundation and published online July 28 and in the October print edition of the foundation’s journal, Inflammatory Bowel Diseases.

A sensor in the device detects and quantifies the presence of two key biomarkers associated with inflammatory bowel disease: interleukin-1β and C-reactive protein (CRP). The study is the first to establish that CRP is present in human sweat and the first to show that the two biomarkers can be detected in sweat.

Dr. Shalini Prasad, department head and professor of bioengineering in the Erik Jonsson School of Engineering and Computer Science and the study’s principal investigator, said the technology could provide a warning but not a diagnosis

Read More
Read More

Cancer Biomarkers Market Opportunities, Size, Share, Emerging Trends, Technological Innovation and Forecasts

The MarketWatch News Department was not involved in the creation of this content.

Sep 29, 2020 (AmericaNewsHour) —
Global Cancer Biomarkers Market was valued at USD 13.50 Billion in the year 2017. Global Cancer Biomarkers Market is further estimated to grow at a CAGR of 14% from 2019 to reach USD 37.94 Billion by the year 2025.
The Global Cancer Biomarkers is segmented as by cancer type, by profiling technology, by biomarkers, and by region. On the basis of the type of cancer the Market is segmented as Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Others of which breast cancer holds the highest Market share.

On the basis of Profiling Technology, the Global Cancer Biomarkers Market is segmented as OMICS Technology, Imaging Technology, Immunoassays, Cytogenetics, and Bioinformatics of which OMICS Technology is expected to hold the highest Market share in the forecasted period.

Request To Download

Read More
Read More

Cancer Biomarkers Market Development Status, Emerging Technologies, Regional Trends and Comprehensive Research Study 2025

The MarketWatch News Department was not involved in the creation of this content.

Sep 23, 2020 (AmericaNewsHour) —
Market Overview:

The global Cancer Biomarkers Market was valued at USD 10.19 billion in 2016 and is projected to reach USD 28.03billion by 2025, growing at a CAGR of 11.9% from 2017 to 2025.

Cancer Biomarkers have high usage in Cancer diagnostics and treatment, especially in Tissue specific therapies. Therefore market of this genetically engineered product is seeing high values in terms of market value.

The Final Report will cover the impact analysis of COVID-19 on this industry:

Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10008242

Sample Infographics:

Market Dynamics:
1. Market Drivers
1.1 Increasing Technological Developments
1.2 Growingnumber of cancer Patients and usage of biomarkers
1.3 Increasing research in biomarkers
2. Market Restraints
2.1 Reimbursements Risks
2.2 High investment and uncertainty of favorable profits
2.3 Technicality concerns

Market Segmentation:
1. Global Cancer

Read More
Read More